Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on November 9, 2026

Nov. 9, 2026

Allogene Therapeutics Reports First Clinical Data from Phase 1 RESOLUTION Study of ALLO-329 in Autoimmune Disease

Indeterminate GlobeNewswire

Nov. 9, 2026

Mentari Therapeutics to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 9, 2026

BioVie Presents New Biomarker Data from the ADDRESS-LC Trial of Bezisterim in Long COVID at the NIH RECOVER-TLC Third Annual Workshop

Indeterminate GlobeNewswire

Nov. 9, 2026

Mereo BioPharma Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 9, 2026

Achieve Life Sciences Becomes AchieveRx, The Quit Company, and Will Trade Under the Ticker QUIT

Indeterminate GlobeNewswire

Nov. 9, 2026

Iambic to participate in Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

Nov. 9, 2026

AEON Biopharma Submits IND for Comparative Pharmacodynamic Study of ABP-450

Indeterminate GlobeNewswire

Nov. 9, 2026

Adneuris Therapeutics Reaches Key Regulatory Milestone with FDA Submission of New Drug Application for Cebranopadol in Moderate-to-Severe Acute Pain

Indeterminate GlobeNewswire

Nov. 9, 2026

Neutrolis Doses First Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis in Phase 1b LIBERATE-I Trial of NTR-1011 and Will Present Phase 1a Data at ACR Convergence 2026

Indeterminate GlobeNewswire

Nov. 9, 2026

Tectonic Therapeutic to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 9, 2026

Monopar Presents Data Highlighting Residual Disease Burden in Treatment-Experienced Wilson Disease Patients and Long-Term Molybdenum Safety Data for ALXN1840 at AASLD – The Liver Meeting® 2026

Indeterminate GlobeNewswire

Nov. 9, 2026

ADARx Pharmaceuticals to Present at the UBS Global Biopharma Conference

Indeterminate GlobeNewswire

Nov. 9, 2026

R1 and Ascension Extend Partnership Through 2037 Leveraging Phare OS to Advance a Technology-First Revenue Cycle

Indeterminate GlobeNewswire

Nov. 9, 2026

Eos SENOLYTIX’s PTC-2105 Reduced Semaglutide-Associated Lean-Mass Loss in Aged Mice: Data to Be Presented at 19th Sarcopenia, Cachexia & Wasting Disorders International Conference

Indeterminate GlobeNewswire

Nov. 9, 2026

OneMedNet Partners to Combine First-Party Multimodal Clinical Data with Comprehensive Patient-Journey AI Analytics, Expanding Commercial Reach Through 13th Channel Partnership

Indeterminate GlobeNewswire

Nov. 9, 2026

Jasper Therapeutics, Inc. Announces Results of the Offer to Purchase Relating to Its Warrants

Indeterminate GlobeNewswire

Nov. 9, 2026

Pluri Adds ISO 9001 and ISO 13485 Certifications to Support PluriCDMO Commercial Expansion

Indeterminate GlobeNewswire

Nov. 9, 2026

Profound Medical to Participate in the Stifel 2026 Healthcare Conference

Indeterminate GlobeNewswire

Nov. 9, 2026

Cognition Therapeutics Invited to Participate in 2026 Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

Nov. 9, 2026

PharmAla Biotech Signs Supply and Data Agreement with Aalborg University Hospital for Danish Randomized Trial of MDMA-Assisted Treatment for Service-Related PTSD

Indeterminate GlobeNewswire